Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5199394
Max Phase: Preclinical
Molecular Formula: C27H36ClN3O2
Molecular Weight: 470.06
Associated Items:
ID: ALA5199394
Max Phase: Preclinical
Molecular Formula: C27H36ClN3O2
Molecular Weight: 470.06
Associated Items:
Canonical SMILES: CCN(CC)CCNC(=O)CC(CC(=O)N(C)C1Cc2ccccc2C1)c1ccc(Cl)cc1
Standard InChI: InChI=1S/C27H36ClN3O2/c1-4-31(5-2)15-14-29-26(32)18-23(20-10-12-24(28)13-11-20)19-27(33)30(3)25-16-21-8-6-7-9-22(21)17-25/h6-13,23,25H,4-5,14-19H2,1-3H3,(H,29,32)
Standard InChI Key: HYKXZLSJHPXQOT-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 470.06 | Molecular Weight (Monoisotopic): 469.2496 | AlogP: 4.29 | #Rotatable Bonds: 11 |
Polar Surface Area: 52.65 | Molecular Species: BASE | HBA: 3 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: | CX Basic pKa: 9.04 | CX LogP: 3.97 | CX LogD: 2.32 |
Aromatic Rings: 2 | Heavy Atoms: 33 | QED Weighted: 0.53 | Np Likeness Score: -0.99 |
1. Lv YB, Chen C, Yu QM, Lyu L, Peng YF, Tan XD.. (2022) Synthesis and biological evaluation of novel pentanediamide derivatives as S-adenosyl-l-homocysteine hydrolase inhibitors., 72 [PMID:35809817] [10.1016/j.bmcl.2022.128880] |
Source(1):